- Home
- ENVB vs OCTO Comparison
ENVB vs OCTO Comparison
Compare ENVB & OCTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENVB
- OCTO
- Stock Information
- Founded
- ENVB 1994
- OCTO 1966
- Country
- ENVB United States
- OCTO United States
- Employees
- ENVB N/A
- OCTO N/A
- Industry
- ENVB Biotechnology: Pharmaceutical Preparations
- OCTO
- Sector
- ENVB Health Care
- OCTO
- Exchange
- ENVB Nasdaq
- OCTO Nasdaq
- Market Cap
- ENVB 4.1M
- OCTO 4.4M
- IPO Year
- ENVB N/A
- OCTO N/A
- Fundamental
- Price
- ENVB $0.35
- OCTO $1.74
- Analyst Decision
- ENVB Strong Buy
- OCTO
- Analyst Count
- ENVB 1
- OCTO 0
- Target Price
- ENVB $10.00
- OCTO N/A
- AVG Volume (30 Days)
- ENVB 1.0M
- OCTO 1.6M
- Earning Date
- ENVB 11-14-2024
- OCTO 11-14-2024
- Dividend Yield
- ENVB N/A
- OCTO N/A
- EPS Growth
- ENVB N/A
- OCTO N/A
- EPS
- ENVB N/A
- OCTO N/A
- Revenue
- ENVB N/A
- OCTO $39,835,256.00
- Revenue This Year
- ENVB N/A
- OCTO N/A
- Revenue Next Year
- ENVB N/A
- OCTO N/A
- P/E Ratio
- ENVB N/A
- OCTO N/A
- Revenue Growth
- ENVB N/A
- OCTO N/A
- 52 Week Low
- ENVB $0.30
- OCTO $1.26
- 52 Week High
- ENVB $2.92
- OCTO $4.86
- Technical
- Relative Strength Index (RSI)
- ENVB 46.61
- OCTO 49.02
- Support Level
- ENVB $0.35
- OCTO $1.56
- Resistance Level
- ENVB $0.39
- OCTO $2.22
- Average True Range (ATR)
- ENVB 0.05
- OCTO 0.27
- MACD
- ENVB -0.00
- OCTO -0.02
- Stochastic Oscillator
- ENVB 19.56
- OCTO 20.20
About ENVB Enveric Biosciences Inc.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders. The company's lead program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. Enveric is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, being studied as a treatment of psychiatric disorders.
About OCTO Eightco Holdings Inc.
Eightco Holdings Inc operates in three main businesses: Forever 8 Inventory Cash Flow Solution, Web3 Business, and Packaging Business. Forever 8 focuses on purchasing inventory for e-commerce retailers and is part of its Inventory Solution Business. Web3 Business but has no intention of continuing this business at this time. The Packaging Business manufactures and sells custom packaging for a wide variety of products and helps customers generate brand awareness and promote brand image through packaging. The Company's two reportable segments were the Inventory Management Solutions segment and the Corrugated segment. Key revenue is generated from Inventory Management Solutions segment.